# Centene Corporation > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Centene Corporation). ## Overview Centene Corp. is a U.S. managed care company built around government-sponsored and underserved populations, with a mission centered on Medicaid, Medicare, and Marketplace members. It operates state-based health plans and local brands that are designed to work closely with providers, policymakers, and community organizations. The company also has adjacent businesses in specialty pharmacy and behavioral health, which broaden its care-management footprint. Centene’s model depends on winning and retaining public and commercial contracts while managing medical cost trends, regulatory requirements, and local market execution. ## Products & services • Medicaid managed care health plans • Medicare Advantage and Medicare Prescription Drug Plans • Health Insurance Marketplace plans • Specialty pharmacy services (AcariaHealth) • Behavioral health services (Magellan Health) • ICHRA-compatible off-exchange individual plans • Provider and care coordination programs - **Medicaid** (55%) — State Medicaid managed care plans for low-income and underserved members. - **Medicare** (20%) — Medicare Advantage and Medicare Part D plans for seniors and eligible members. - **Commercial** (15%) — Marketplace and other commercial individual/family health plans, including ICHRA-compatible offerings. - **Other** (10%) — Specialty pharmacy, behavioral health, and related services businesses. - Medicaid managed care plans for state-sponsored populations - Medicare Advantage and Medicare Part D prescription drug plans - Marketplace individual and family health insurance plans - Specialty pharmacy services for complex and chronic conditions - Behavioral health services and managed behavioral care - ICHRA-compatible off-exchange health plan offerings - Care management, quality improvement, and community support programs ## Customers Centene’s core customers are state Medicaid agencies and other public payers that award managed care contracts based on quality, network access, administrative performance, and local market presence. A second major customer group is Medicare members, including beneficiaries using Medicare Advantage and Medicare Prescription Drug Plans, where plan quality, supplemental benefits, and provider access drive enrollment. The company also serves individuals and families buying coverage through the Health Insurance Marketplace, including off-exchange products designed for ICHRA adoption. In its Other segment, Centene sells specialty pharmacy and behavioral health services to health plans, employers, unions, government agencies, and third-party administrators. Across these segments, the buying decision is driven by affordability, network breadth, service quality, and the ability to manage care and outcomes for complex populations. - **State Medicaid programs** (primary) — Buy managed care coverage and administration because Centene can serve large, complex, low-income populations under state contracts. - **Medicare members** (primary) — Buy Medicare Advantage and Part D plans for coverage, supplemental benefits, and network access. - **Marketplace individuals and families** (secondary) — Buy individual health plans for affordability and access, including ICHRA-compatible offerings. - **Commercial employers and ICHRA adopters** (secondary) — Buy off-exchange plans to give employees more choice and predictable premiums. - **Behavioral health and specialty pharmacy clients** (secondary) — Buy outsourced care management, pharmacy distribution, and behavioral health services to improve access and outcomes. - State Medicaid agencies that award managed care contracts - Medicare beneficiaries seeking Advantage and Part D coverage - Marketplace individuals and families buying affordable coverage - Employers using ICHRA-compatible reimbursement arrangements - Health plans and MCOs buying behavioral health services - Government agencies, unions, and TPAs using Magellan services - Providers and payers using specialty pharmacy support ## Geography Centene’s business is overwhelmingly U.S.-centric, with operations organized around state-based health plans and contracts with U.S. federal and state agencies. Geography matters because Medicaid and many other programs are regulated and funded at the state level, so local market execution, provider networks, and state-specific rate setting are central to performance. The company’s local-brand model is designed to adapt to different state rules and competitive conditions rather than rely on a single national product. Its exposure is therefore tied to U.S. policy changes, state contract renewals, and regional differences in healthcare utilization and reimbursement. The reports provided do not disclose a country-level revenue split, so no country breakdown is available from the excerpted materials. - Primarily U.S. operations with state-by-state managed care contracts - Medicaid exposure is tied to state funding and state-specific regulation - Medicare and Marketplace businesses are also U.S.-based - Local brands and local teams are used to win regional contracts - No country-level revenue split was disclosed in the provided excerpts ## Strategy Centene’s near-term strategy is to improve productivity, reduce organizational costs, and deploy capital through stock repurchases, portfolio optimization, and refinancing opportunities. The company is also focused on strengthening member and provider experience, which is important because contract awards and retention depend on quality, network access, and service performance. In its growth businesses, Centene is expanding Medicare and Marketplace offerings, including ICHRA-compatible plans, to capture a broader commercial addressable market. The company is also managing its portfolio by exiting non-core assets, including the planned divestiture of remaining Magellan Health businesses, while preserving scale in core managed care. Liquidity, dividend capacity from subsidiaries, and access to the revolving credit facility remain important to support operations and capital deployment. - **Cost and productivity improvement** (short-term) — Lower administrative cost and better operating efficiency support margins in a regulated, price-sensitive business. - **Commercial growth in Medicare and Marketplace** (medium-term) — Diversifies the revenue base beyond Medicaid and captures demand from seniors and individual buyers. - **Portfolio optimization and divestitures** (medium-term) — Focuses capital and management attention on core managed care while reducing complexity. - **Capital deployment and balance sheet flexibility** (short-term) — Supports shareholder returns and funding needs while preserving liquidity under regulatory constraints. - Improve productivity and reduce organizational costs - Use capital deployment tools such as share repurchases and refinancing - Expand Medicare and Marketplace membership, including ICHRA-compatible plans - Strengthen member and provider experience to support contract wins - Optimize the portfolio by divesting non-core businesses - Maintain liquidity and access to subsidiary dividends and credit facilities ## Risks Centene’s largest business risk is medical cost trend and rate adequacy: if utilization or acuity rises faster than state and CMS reimbursement, margins and cash flow can deteriorate quickly. Because the company relies on third-party vendors, claims systems, and data infrastructure, operational failures or cyber incidents could disrupt service delivery and expose sensitive health information. Regulatory and contract risk is also material, since Medicaid and Medicare businesses depend on state and federal rules, minimum medical loss ratio requirements, and performance metrics that can trigger premium refunds or limit revenue recognition. Competitive pressure from other managed care organizations, provider consolidation, and new entrants can reduce membership growth and pricing flexibility. The company also faces impairment and integration risk from acquisitions and portfolio changes, as shown by the large goodwill impairment in 2025 and the planned divestiture of Magellan businesses. - **Medical cost trend and rate adequacy** [high] — If medical utilization, acuity, or pharmacy costs rise faster than reimbursement, Centene may not recover its claims costs. - **Regulatory and contract compliance** [high] — State and CMS contracts can require minimum MLRs, quality metrics, and premium refunds, directly affecting revenue and earnings. - **Cybersecurity and systems disruption** [high] — Claims processing and member data depend on secure IT systems and vendors, so breaches or outages can create service and legal costs. - **Competitive pressure and industry consolidation** [medium] — Stronger rivals or provider consolidation can reduce Centene’s ability to win contracts, retain members, and control medical costs. - **Goodwill and intangible asset impairment** [high] — The company recorded a large goodwill impairment in 2025, showing that valuation assumptions can change materially. - Medical cost trend may outpace rate increases and hurt margins - State and CMS contracts can require premium refunds or performance thresholds - Cybersecurity and systems failures could disrupt claims and member services - Third-party vendor dependence increases operational and compliance risk - Competition may reduce membership growth and pricing flexibility - Goodwill and intangible assets can be impaired if business outlook weakens - Portfolio divestitures and acquisitions can create execution risk ## Accounting Centene’s accounting is heavily influenced by estimates tied to medical claims liability, revenue recognition, and goodwill valuation. Revenue is recorded using membership and eligibility data from states and CMS, and those records are adjusted monthly for retroactive additions and deletions, so reported revenue can change as new information arrives. The company also estimates reductions to revenue for minimum medical loss ratio programs, cost-sharing arrangements, and performance-based contracts, which means timing and measurement judgments can materially affect quarterly results. Goodwill and intangible assets are a major judgment area: in 2025 the company recorded a $6.7 billion goodwill impairment after a quantitative fair value assessment using discounted cash flow and market multiples. Regulatory capital restrictions also matter because a significant amount of subsidiary capital is unavailable for dividends, affecting liquidity analysis and parent-level cash flow. - **Medical claims liability** — Can materially change quarterly medical cost ratios and operating income. - **Revenue recognition and eligibility adjustments** — Can cause revenue volatility and prior-period adjustments. - **Minimum medical loss ratio and performance-based revenue** — Affects premium revenue and margin comparability. - **Goodwill and intangible asset impairment** — Can create large non-cash charges and signal weaker long-term expectations. - **Regulatory capital and dividend restrictions** — Affects liquidity, capital allocation, and debt service flexibility. - Medical claims liability depends on utilization, acuity, and completion factors - Revenue is adjusted for retroactive eligibility changes from states and CMS - MLR and cost-sharing arrangements can reduce revenue through refunds - Performance-based contracts may defer revenue until measurement is reliable - Goodwill impairment reflects judgment on future cash flows and discount rates - Dividend restrictions at regulated subsidiaries affect parent liquidity --- *Last updated: 2026-08-11T04:03:56.228997+00:00*